Towards Healthcare
Biochip Market to Surge USD 42.15 Bn by 2034

Biochip Market Expansion 2025 Driven by Genomics Demand

Projections indicate that, biochip industry is projected to rise from USD 12.75 billion in 2024 to USD 42.15 billion by 2034, reflecting a CAGR of 12.7% over the next decade. The biochip market is growing because biochips have many applications, such as medical diagnostics, drug development, personalized medicine, continuous health monitoring, neurostimulation, assistive services, and smart healthcare systems. North America is dominant in the market due to significant government funding and massive investments in biotechnology research.

Content

  • Insight Code: 6251
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The biochip market in 2025 is valued at USD 14.37 billion and is projected to climb to USD 42.15 billion by 2034, with a CAGR of 12.7% over the forecast period.

North America is currently leading the biochip market share 40% due to the presence of major key players and strong R&D investment.

The biochip market includes six segments by chip type/product, by offering/product category, by application/end market, by technology/platform, by end-user, and by region.

Some key players include Illumina, Inc., Thermo Fisher Scientific, Roche Diagnostics, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions